Poolbeg Pharma signs AI deal with OneThree Biotech to identify new drug targets and treatments for RSV
Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’) a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has…